The legacy of Viagra and its influence on the drug landscape presents a thorny question for shareholders . Initially a hugely successful drug, competitors have significantly diminished its market share , creating obstacles for companies involved to the original patent holder and subsequent formulas. While some companies might profit from niche Viag